Skip to main content
    L

    LivaNova PLC (LIVN)

    Official site

    HEALTHCARE • MEDICAL DEVICES • NASDAQ

    $78.50
    +2.42 (+3.18%)

    Market Cap: $4.20B

    Last updated: Oct 16, 2026 at 1:55 PM ET

    Earnings

    Performance (10Y)

    Beat Rate
    92%(36/39)
    Avg Surprise
    +18.87%
    Streak
    25 Q

    Upcoming Estimates

    Period ending Sep 30, 2026
    EPS Consensus$1.06
    Range$1.02 - $1.13
    10 analysts
    EPS Revisions
    1
    0
    7d
    2
    7
    30d
    EPS Estimate DriftChange to current
    90d ago$1.08-2.3%
    60d ago$1.05+0.4%
    30d ago$1.06+0.2%
    7d ago$1.06+0.2%
    Current$1.06
    Revenue Consensus
    $381M
    Range$378M - $386M
    9 analysts
    Period ending Dec 31, 2026
    EPS Consensus$1.31
    Range$1.27 - $1.35
    10 analysts
    Revenue Consensus
    $414M
    Range$394M - $424M
    10 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Dec 26EST
    		-$1.31---
    Sep 26EST
    		-$1.06---
    Jun 26
    Reported Aug 5
    		$1.02$0.96+6.25%Beat-2.9%
    Mar 26
    Reported May 6
    		$0.98$0.90+8.89%Beat+11.4%
    Dec 25
    Reported Feb 25
    		$0.86$0.81+6.12%Beat+6.2%
    Sep 25
    Reported Nov 5
    		$0.97$0.78+24.36%Beat+7.8%
    Jun 25
    Reported Aug 6
    		$1.05$0.87+20.69%Beat+12.9%
    Mar 25
    Reported May 7
    		$0.88$0.76+15.79%Beat+20.5%
    Dec 24
    Reported Feb 25
    		$0.81$0.80+1.17%Beat-6.9%
    Sep 24
    Reported Oct 30
    		$0.90$0.72+25.00%Beat+23.3%
    Jun 24
    Reported Jul 31
    		$0.93$0.78+19.23%Beat+19.2%
    Mar 24
    Reported May 1
    		$0.73$0.49+48.98%Beat+69.8%
    Dec 23
    Reported Feb 21
    		$0.87$0.77+12.99%Beat+7.4%
    Sep 23
    Reported Nov 1
    		$0.73$0.64+14.06%Beat+25.9%
    Jun 23
    Reported Jul 26
    		$0.78$0.54+44.44%Beat+47.2%
    Mar 23
    Reported May 3
    		$0.43$0.39+10.26%Beat-10.4%
    Dec 22
    Reported Feb 22
    		$0.81$0.73+10.96%Beat+42.1%
    Sep 22
    Reported Nov 2
    		$0.58$0.55+5.45%Beat-14.7%
    Jun 22
    Reported Aug 3
    		$0.53$0.52+1.92%Beat+1.9%
    Mar 22
    Reported May 4
    		$0.48$0.48+0.00%Beat+37.1%
    Dec 21
    Reported Feb 23
    		$0.57$0.52+9.62%Beat-19.7%
    Sep 21
    Reported Nov 3
    		$0.68$0.44+54.55%Beat+78.9%
    Jun 21
    Reported Jul 28
    		$0.52$0.33+57.58%Beat+446.7%
    Mar 21
    Reported Apr 28
    		$0.35$0.15+133.33%Beat+6.1%
    Dec 20
    Reported Feb 24
    		$0.71$0.68+4.41%Beat-29.0%
    Sep 20
    Reported Oct 29
    		$0.38$0.20+90.00%Beat-54.8%
    Jun 20
    Reported Jul 29
    		$-0.15$-0.30+50.00%Beat-121.4%
    Mar 20
    Reported Apr 29
    		$0.33$0.43-23.26%Miss-38.9%
    Dec 19
    Reported Feb 26
    		$1.00$0.98+2.04%Beat-10.7%
    Sep 19
    Reported Oct 30
    		$0.84$0.75+12.00%Beat+7.7%
    Jun 19
    Reported Jul 31
    		$0.70$0.65+7.69%Beat-27.1%
    Mar 19
    Reported May 1
    		$0.54$0.56-3.57%Miss-20.6%
    Dec 18
    Reported Feb 27
    		$1.12$1.10+1.82%Beat+25.8%
    Sep 18
    Reported Oct 31
    		$0.78$0.90-13.33%Miss-16.1%
    Jun 18
    Reported Aug 1
    		$0.96$0.92+4.35%Beat-5.0%
    Mar 18
    Reported May 2
    		$0.68$0.65+4.62%Beat-4.2%
    Dec 17
    Reported Feb 28
    		$0.89$0.77+15.58%Beat+4.7%
    Sep 17
    Reported Nov 2
    		$0.93$0.78+19.23%Beat-
    Jun 17
    Reported Aug 9
    		$1.01$0.83+21.69%Beat-
    Mar 17
    Reported May 3
    		$0.71$0.67+5.97%Beat-
    Dec 16
    Reported Mar 1
    		$0.85$0.81+4.94%Beat-

    Key Metrics

    Valuation
    P/E Ratio20.50EV/EBITDA19.38x
    Price/FCF29.79xFCF Yield3.36%
    Profitability
    Profit Margin12.80%Operating Margin13.50%
    ROE15.40%ROIC9.44%
    Financial Health
    Debt/Equity0.22xInterest Coverage3.31x
    Current Ratio1.45xQuick Ratio1.21x
    Trading Statistics
    Beta0.88Avg Volume676.98K
    52-Week High$85.7652-Week Low$48.82

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$76.29
    SMA 20$76.61
    SMA 50$78.39
    SMA 200$71.96
    EMA 10$76.71
    EMA 20$76.96
    EMA 50$77.77
    EMA 200$71.84

    MACD

    Line: -0.50Signal: -0.79Hist: 0.29

    ADX

    ADX: 20.9+DI: 17.6-DI: 17.3

    Aroon & PSAR

    Aroon Up8.0
    Aroon Down40.0
    PSAR$74.55

    Bollinger Bands

    Upper Band$78.87
    Lower Band$74.35
    %B Position591%(Upper)
    Band Width0.92

    RSI (14-Day)

    Neutral
    55.0

    Momentum Oscillators

    Stoch %K64.0
    Stoch %D57.7
    Williams %R-12.5
    ROC (10d)5.1%
    Momentum3.80
    CCI (20d)110.7
    MFI (14d)51.5

    Volatility Measures

    ATR (14d)$2.17(2.8%)
    StdDev (20d)1.13
    Hist Vol22.9%(Moderate)

    Volume Flow

    VWAP$77.94
    OBV20.3M
    AD Line22.7M
    CMF (20d)0.138

    Volume Metrics

    Avg Vol (20d)678.6K
    Vol Ratio1.1x
    VWMA (20d)$76.70

    Pivot Points

    R3$79.35
    R2$78.31
    R1$77.20
    Pivot Point$76.16
    S1$75.05
    S2$74.01
    S3$72.90

    Advanced Oscillators

    TSI-7.96
    Ultimate Osc57.5
    KST-37.32

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$390.60M$362.26M$360.86M$357.80M$352.52M$316.86M$321.83M$318.12M$318.57M$294.91M$310.13M$286.11M
    Cost of Revenue$116.90M$117.41M$121.08M$112.90M$113.54M$96.08M$102.48M$92.86M$103.70M$87.52M$119.97M$84.31M
    Gross Profit$273.70M$244.85M$239.78M$244.90M$238.99M$220.78M$219.35M$225.26M$214.88M$207.39M$190.17M$201.80M
    Operating Expenses$224.20M$192.66M$197.16M$190.90M$184.81M$172.16M$182.33M$189.65M$174.71M$191.14M$278.16M$197.34M
    R&D$53.70M$49.09M$52.08M$48.60M$47.19M$37.88M$43.31M$48.80M$44.74M$45.66M$46.17M$46.54M
    SG&A$158.13M$143.57M$143.37M$138.52M$137.78M$133.67M$135.62M$131.66M$129.12M$129.86M$133.33M$134.80M
    Operating Income$49.50M$52.19M$42.62M$54.00M$54.18M$48.62M$37.02M$35.62M$40.17M$16.25M$-87,990,000$4.46M
    Interest Income$3.83M$3.55M$4.46M$3.90M$4.18M$6.44M$8.58M$7.14M$7.34M$7.02M$6.03M$5.92M
    Interest Expense$7.20M$8.29M$19.79M$10.86M$12.28M$15.29M$15.77M$15.88M$15.53M$15.89M$15.62M$14.99M
    Income Before Tax$18.50M$26.63M$27.65M$33.90M$33.31M$-315,666,000$56.48M$44.48M$21.56M$-34,200,000$-94,296,000$-2,010,000
    Income Tax Expense$-90,200,000$4.34M$-3,207,000$7.11M$6.15M$11.66M$589,000$11.53M$5.23M$7.72M$-110,652,000$5.31M
    Net Income$108.60M$22.30M$30.88M$26.80M$27.16M$-327,322,000$55.89M$32.95M$16.33M$-41,943,000$16.34M$-7,318,000
    EBITDA$43.90M$50.52M$62.15M$59.98M$60.64M$-285,689,000$84.83M$73.45M$49.41M$-5,168,000$-62,800,000$28.09M
    EBIT$25.70M$34.92M$47.44M$44.76M$45.60M$-300,360,000$72.25M$60.32M$37.12M$-18,307,000$-78,675,000$13.01M
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about LIVN

    Government Contracts

    Gov Obligations (TTM)
    $1.73M
    Gov Obligations / Revenue
    0.1%
    Obligations YoY
    -1.3%
    Active Awards
    39
    New Awards (TTM)
    25
    Avg Remaining Term
    6.7 mo

    Top agency: Department of Veterans Affairs at 96.3% of trailing twelve month obligations across 2 agencies

    Recent Awards

    Award IDAgencyObligatedStart
    36C25926F0121Department of Veterans AffairsDepartment of Veterans Affairs$187906Feb 27, 2026
    36C24626P0248Department of Veterans AffairsDepartment of Veterans Affairs$120369Dec 23, 2025
    36C24826P0494Department of Veterans AffairsDepartment of Veterans Affairs$87219Feb 25, 2026
    36C25026P0263Department of Veterans AffairsDepartment of Veterans Affairs$82168Feb 6, 2026
    36C26226C0006Department of Veterans AffairsDepartment of Veterans Affairs$81225Oct 1, 2025
    36C24726P0738Department of Veterans AffairsDepartment of Veterans Affairs$58377Aug 17, 2026
    36C24825P2072Department of Veterans AffairsDepartment of Veterans Affairs$56709Sep 30, 2025
    36C26226P1212Department of Veterans AffairsDepartment of Veterans Affairs$51417Jul 1, 2026
    36C25026P0925Department of Veterans AffairsDepartment of Veterans Affairs$50822Jul 24, 2026
    36C25026P0734Department of Veterans AffairsDepartment of Veterans Affairs$50822May 27, 2026

    Federal contract obligations are bookings recorded by the awarding agency, not recognized revenue. They can exceed 100% of revenue and can be negative when contracts are de-obligated. Source: USAspending.gov prime awards, data through Jul 31, 2026.

    LIVN Valuation and Fair Value

    P/E
    20.5x
    Forward P/E
    16.0x
    EV/EBITDA
    19.4x
    P/FCF
    29.8x
    PEG
    0.9x
    P/B
    3.3x
    See GNG's fair value

    LIVN Profitability: Margins, ROIC and FCF

    Gross margin
    68.2%
    Operating margin
    13.5%
    Net margin
    12.8%
    ROIC
    9.4%
    ROE
    15.4%
    FCF margin
    10.1%
    FCF yield
    3.4%

    LIVN Competitors

    CompanyTicker
    Heartflow, Inc. Common StockHTFL
    Dianthus Therapeutics Inc.DNTH
    Integer Holdings CorpITGR
    ICU Medical IncICUI
    Diversified Healthcare TrustDHCNL
    Regencell Bioscience Holdings LtdRGC
    Akero Therapeutics IncAKRO
    Premier IncPINC

    Sector: Healthcare

    LIVN Analyst Ratings

    Consensus
    Buy
    Analysts
    10
    Strong Buy
    2
    Buy
    6
    Hold
    2
    Sell
    0
    Strong Sell
    0

    LIVN Bull Case vs Bear Case

    Bull case

    • LIVN beat EPS estimates in 100.0% of its last 8 reported quarters.
    • LIVN grew quarterly revenue 10.8% year over year.
    • 80.0% of LIVN's analyst ratings are Buy or Strong Buy.

    LIVN Earnings: Beat Rate and Next Report

    Beat rate
    8 of 8 quarters (100.0%)
    Average surprise
    13.5%
    EPS estimate (fiscal period ending Sep 30, 2026)
    $1.06
    Estimate revisions (30 days, fiscal period ending Sep 30, 2026)
    2 up, 7 down

    Frequently Asked Questions About LIVN

    Does LIVN pay dividends?

    LivaNova PLC (LIVN) does not currently pay a regular dividend.

    What is LIVN's P/E ratio?

    LivaNova PLC has a price-to-earnings (P/E) ratio of 20.50.

    What is LIVN's market cap?

    LivaNova PLC (LIVN) has a market capitalization of $4.20B with a current stock price of $78.50.

    Related stocks

    Sector: Healthcare

    All stocks starting with L

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In